🔗 Share this article

A shadow market for unlicensed slimming drugs is being driven by social media fitness personalities and vendors on messaging platforms, according to recent findings.

Investigational Treatment Gaining Traction Online

The experimental drug, which is still in research studies, is being promoted by online personalities for its alleged fat-burning properties. Viewers are urged to contact these profiles directly for source information, while also obtaining discount codes.

Thriving Trade on Social Networks

Separately, a robust trade exists on messaging services, where groups with thousands of participants share comparison photos, administration instructions and claims of next-day British shipping. Vendors market the substance there before directing buyers to other platforms for transactions.

Learning About The Experimental Drug

Retatrutide is an investigational injection developed by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – GLP-1, GIP and pancreatic hormone. Early trials suggest it could help individuals reduce up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being hailed digitally as the successor to Ozempic.

Medical Experts Voice Worries

However, physicians and chemists have warned that the sale of what remains an unapproved medication in the UK is a cause for concern and could result in individuals injecting products of unknown origin.

Several experts said the demand for the experimental drug could be linked to the increasing cost of approved weight loss treatments such as Mounjaro.

Regulatory Position and Implementation

Selling the unapproved drug on TikTok or Telegram is prohibited in the United Kingdom, as it is an unapproved drug that cannot be marketed or distributed for human use under the Human Medicines Regulations 2012.

Several content creators try to circumvent the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but promotion and distribution can still violate medicines, marketing, and customer regulations, potentially leading to penalties, prosecution or prison.

Service Reaction and Material Removal

According to the social media company, the platform has taken down problematic content and prohibited related hashtags and query recommendations. The company said it was dedicated to keeping the service secure and allocating resources in strengthening enforcement strategies.

Digital Trading Operations

Investigations also discovered groups with up to 9,000 participants marketing retatrutide using the platform's integrated search feature, which operates like a online catalog. Typing “retatrutide” instantly brings up groups with thousands of members, filled with images of weight loss, glowing testimonials and step-by-step instructions for preparing or injecting at home.

Within moments of joining one group, a vendor shared contact information, where the majority of transactions occur. The vendor provided an guidebook and guaranteed shipping within two days. When questioned whether the substance was authentic, one seller said: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. None inquired about body mass, medical conditions or previous experience.

Item Details and Pricing

Within these groups, messages display dark colored packages with Royal Mail labels, stating to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”

Customers can choose between powder vials, prepared at residence with purified liquid, or ready-to-use pens usually sold at 160 pounds for 20 milligrams. When questioned how much time a injector should last, vendors give contradictory responses ranging from a few weeks to “depends on your body”.

Service Oversight and Safety Actions

A spokesperson for the messaging service stated it actively moderated harmful content on its service including content that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“People are administering materials they can’t verify. Even if the science behind this drug is sound, these online products may not include what they claim,” stated Jason Murphy, the head of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor connected the increase in interest to recent cost increases for approved weight-loss drugs such as Mounjaro. “With costs rising, individuals are turning to online platforms. But counterfeit treatments are highly risky. You cannot know what’s contained or whether the conditions they were made in was clean,” she explained.

Her team has previously seen individuals harmed by personal administration from unconfirmed sources. “We understand the frustration, but buying from Telegram or WhatsApp is taking chances with your well-being,” said the doctor. “These substances could be contaminated or improperly measured.”

Producer Position

A representative from Eli Lilly stated the substance was in phase 3 clinical trials and had not been reviewed or approved by any regulatory agency anywhere in the world. “Consequently at this point no one can sell [it] for human use,” they said, noting that any item “misleadingly claiming itself as a Lilly investigational product not yet approved … may subject patients to possibly significant medical dangers”.